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Background: Transfemoral cardiac catheterisation is an invasive medical procedure used for therapeutic or diagnostic
purposes. Postoperative bed rest can prevent a number of complications such as bleeding and haematoma formation
and can result in side effects such as back pain and urinary discomfort. Currently, there is no consensus regarding the
optimal length of bed rest. Our objective is to assess the effects of post-catheterisation length of bed rest on bleeding
and haematoma, other vascular complications, patient symptoms and patient discomfort, among patients who
underwent transfemoral cardiac catheterisation.
Methods: We wrote this protocol in accordance with the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses Protocols statement. We defined the search query by using the PICO framework (Population: Patients
undergoing cardiac catheterisation; Intervention: early mobilisation; Comparison: late mobilisation; Outcomes: early and
late complications). We will search six biomedical databases and five online registries to obtain both published and
unpublished studies. We will include randomised controlled trials and quasi-randomised controlled trials, and their
quality will be independently appraised with the Cochrane Effective Practice and Organisation of Care criteria for quality
assessment. We will carry out a pairwise meta-analysis and network meta-analysis to estimate the overall intervention
effects from both direct and indirect comparisons.
Discussion: This review may have considerable implications for practice and help to achieve an effective and efficient
management of patients who underwent cardiac catheterisation. This review will be grounded in an expanded search
of 11 resources and will employ innovative statistical methods such as network meta-analysis.
Systematic review registration: PROSPERO registration number: CRD42014014222.
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Cardiac catheterisation comprises a group of therapeutic
or diagnostic procedures in which placement of cardiac
catheter is performed by skin puncture rather than by
incision [1]. Examples of such procedures include angi-
ography, which is undertaken for diagnostic purposes,
and percutaneous coronary intervention, which is car-
ried out for both diagnostic or therapeutic purposes [2].* Correspondence: alberto.dalmolin@gmail.com
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unless otherwise stated.It is estimated that approximately 2.2 million patients
receive percutaneous coronary intervention worldwide
every year [3].
In such procedures, transfemoral puncture is the most
common approach because of the larger diameter of such
artery [2,4-8]. To reduce complications, manual or mech-
anical application of a firm pressure above the puncture
site is needed [9]. Bed rest in recumbent position and im-
mobilisation of the affected leg are also required for such
patients after sheath removal [10,11]. Restricted bed rest
and leg immobilisation have been considered essential to
reduce the risk of developing complications [2].ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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size and local policy or individual experience [2,7,12-14].
Although both minor and major vascular complications
should be prevented, prolonged bed rest has been identi-
fied as the most difficult component of post-cardiac cath-
eterisation care [15]. The most frequent complaints of
patients during prolonged bed rest are back pain and urin-
ary discomfort, including urinary retention and difficulty
with evacuation when in recumbent position [2,10,16].
Patient anxiety and anger due to the unmet needs for
comfort are also often noted [17,18].
Objectives
This study aims to assess the effects of post-catheterisation
length of bed rest on bleeding and haematoma, other vas-
cular complications, patient symptoms and patient discom-
fort, among patients who underwent transfemoral cardiac
catheterisation.
Methods/design
We have written this protocol in accordance with the Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analyses Protocols (PRISMA-P) [19], and we will conduct
this systematic review in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) [20] statement. We will include both
randomised controlled trials and quasi-randomised con-
trolled trials with at least two study groups. We have de-
fined the search query by using the following PICO
framework [21] (see Table 1).
Participants
The study population will include patients undergoing
transfemoral cardiac catheterisation. There will be no re-
strictions by patient age, gender, race, comorbidity, health-
care setting or other characteristics.
Interventions and comparisons
The intervention of interest is duration of bed rest, de-
fined as lying in bed without permission to get up for
any reasons. We will compare early mobilisation with late
mobilisation which will be defined based on the studies in-
cluded in a previous work [22]: 0 to 1.9 h, 2 to 3.9 h, 4 toTable 1 PICO
PICO framework Description
Population Patients undergoing transfemoral cardi
age, gender, race, comorbidity, setting
Interventions and comparison Lengths of bed rest. Since definition of
intervention and comparison groups o
1.9 h, 2 to 3.9 h, 4 to 5.9 h, 6 to 7.9 h, 8
Outcomes Common and early complications such
and arteriovenous fistulae. Patient symp5.9 h, 6 to 7.9 h, 8 to 11.9 h, 12 h or greater. We anticipate
that for some studies published after the review of Allen
et al. [22], bed rest duration might fall into the same cat-
egory for two or more study arms of the same study, pre-
venting estimation of intervention effect. In such a case,
we would split categories to allow the greatest number of
studies to be included, while keeping the number of cat-
egories as low as possiblea. This approach will (i) allow a
more objective classification of intervention categories, as
definitions of ‘early mobilisation’ and ‘late mobilisation’
may vary across studies; (ii) allow inclusion of the studies
whose both arms fall into one of the categories observed
in Allen et al. [22]; and (iii) favour reasonable compatibil-
ity with previous work.Outcome
In accordance with Saldanha et al. [23], we define out-
comes by five items: domain, specific measurements, spe-
cific metric, method, time point.Primary outcomes
Domain: bleeding.
Specific measurement: number of patients presenting vis-
ible areas of bleeding, oozing or haemorrhage at the punc-
ture site.
Specific metric: value at time point.
Method of aggregation: percent.
Time point: 24 h after transfemoral cardiac catheterisa-
tion, or closest time point.
Domain: haematomas.
Specific measurement: number of patients presenting
visible ecchymosis or haematomas at the puncture site,
or ultrasound-confirmed palpable haematomas at the
puncture site.
Specific metric: value at time point.
Method of aggregation: percent.
Time point: 24 h after transfemoral cardiac catheterisa-
tion, or closest time point.Secondary outcomes
Domain: pseudoaneurysm.ac catheterisation. We will not apply restrictions with regard to patient
or other characteristics.
‘early’ or ‘late’ mobilisation may differ across studies, we will define
n the basis of six categories observed in a previous work [22]: 0 to
to 11.9 h, 12 h or greater.
as bleeding, haematomas. Late complications such as pseudoaneurysms
toms such as back pain, urinary discomfort and patient discomfort.
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pseudoaneurysm at the puncture site that can be con-
firmed by ultrasound.
Specific metric: value at time point.
Method of aggregation: percent.
Time point: 2 weeks after transfemoral cardiac cath-
eterisation, or closest time point.
Domain: arteriovenous fistulae.
Specific measurement: number of patients presenting
arteriovenous fistulae at the puncture site that can be
confirmed by ultrasound.
Specific metric: value at time point.
Method of aggregation: percent.
Time point: 2 weeks after transfemoral cardiac cath-
eterisation, or closest time point.
Domain: back pain.
Specific measurement: Numerical Rating Scale or other
scale described by each trial.
Specific metric: value at time point.
Method of aggregation: mean and standard deviation.
Time point: 24 h after transfemoral cardiac catheterisa-
tion, or closest time point.
Domain: urinary discomfort.
Specific measurement: subjective scales of urinary dis-
comfort described by each trial.
Specific metric: value at time point.
Method of aggregation: mean and standard deviation.
Time point: 24 h after transfemoral cardiac catheterisa-
tion, or closest time point.
Domain: patient discomfort.
Specific measurement: subjective scales of patient dis-
comfort described by each trial.
Specific metric: value at time point.
Method of aggregation: mean and standard deviation.
Time point: 24 h after transfemoral cardiac catheterisa-
tion, or closest time point.
Search methods for identification of studies
Electronic searches
We will search six biomedical and nursing research da-
tabases: MEDLINE, EMBASE, Cochrane Database of
Systematic Reviews, CINAHL, SCOPUS, SciELO. Search
strategies are shown in Additional file 1.
Searching other resources
We will explore five registries of studies to obtain both
published and unpublished works (grey literature): Na-
tional Health Service (NHS) evidence, http://www.upto-
date.com, http://clinicaltrials.gov/, http://www.who.int/
ictrp/en/, http://www.controlled-trials.com/.
We will manually inspect previous reviews to obtain
relevant works from their list of references.
We will populate search results including authors, title
and abstracts into Thomson Reuter’s EndNote software,and any duplicates will be automatically removed. Two
authors will independently screen titles and abstracts,
and any disagreement will be solved by a third author.
We will not set any language restrictions and will carry
out translations whenever necessary.
We will retrieve the full texts of selected articles, and
two authors will independently evaluate whether they
are pertinent to this review. Any disagreement will be
solved by a third author.
We will assess agreement between the two screeners
with Cohen’s kappa coefficient. Agreement will be con-
sidered poor if K is lower than 0.20; fair if between 0.21
and 0.40; moderate if between 0.41 and 0.60; good if be-
tween 0.61 and 0.80; and very good if equal to or greater
than 0.81 [24].
Quality assessment of primary studies
We will use the Cochrane Effective Practice and Organ-
isation of Care (EPOC) Risk of Bias tool [25], which is a
two-part tool addressing specific domains such as: se-
quence generation and allocation concealment (selection
bias), blinding of outcome assessor (detection bias), se-
lective outcome reporting (reporting bias) and other
sources of bias. The first part of the tool is intended to
describe what was reported to have happened in the
study. The second part of the tool involves assigning a
judgement related to the risk of bias for each entry, in
terms of low, high or unclear risk. See Additional file 2
for details.
Data extraction
Once articles have been selected for inclusion, data ex-
traction will take place. Two authors will independently
extract data with a standard Excel extraction form in
which all relevant data will be included for each study.
Any disagreement in this phase will be solved by discus-
sion with a third author.
Data collection will comprise four main areas of
information:
1- Article:
* Title
* Author
* Year of publication
* Journal
2- Study characteristics:
* Setting and location of the study
* Number of patients
* Mean patient age
* Duration of bed rest
* Purposes of procedure: diagnostic or therapeutic
intervention
* Setting: elective or emergency
* Size of catheter (potential effect modifier)
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(potential effect modifier)
* Study design (randomised or quasi-randomised)
3- Results (divided by duration of bed rest):
* Number of patients per study group
* Number of patients presenting active bleeding,
including oozing and haemorrhage
* Number of patients presenting haematomas or
ecchymosis
* Number of patients presenting late vascular
complications such as pseudoaneurysms and
arteriovenous fistulae
* Mean and standard deviation of patient
discomfort scales
* Mean and standard deviation of urinary
discomfort scales
* Mean and standard deviation of back pain scales
4- Notes:
* Language of the study and any other information
relevant to this review.
Measures of treatment effect
We will analyse dichotomous outcomes by calculating the
risk ratio (RR) for each included trial, along with the cor-
responding precision of effect estimate expressed by their
95% confidence intervals. For continuous outcome mea-
sures, we expect to pool studies which use different scales
and will thus compute standardised mean difference
(SMD) and its corresponding 95% confidence interval for
each included trial.
Dealing with missing data
Wherever possible, we will contact the authors of the
studies for integration of any missing data. If we are un-
able to obtain information regarding at least one of the
primary outcomes, we will include the study from the
review and exclude it from the meta-analysis. If we are
unable to obtain information needed for quality assess-
ment, we will consider the EPOC criterion of interest to
be at a high or unclear risk of bias, depending on the in-
formation already available for that study.
Assessment of reporting biases
If the number of studies will be sufficient, funnel plots
(that is, scatter plots of the effect estimate from each study
against the standard error) will be used to assess the po-
tential for bias related to the size of the trials, which could
indicate possible publication bias.
Data synthesis
Pairwise meta-analysis
A traditional frequentist pairwise meta-analysis will be
carried out by pooling parameter estimates of includedstudies. Due to the large variability in clinical approaches
for cardiac catheterisation, we will use a random effects
model to account for potential between-study hetero-
geneity. We will perform frequentist pairwise meta-
analysis in R using the metafor package [26].Network meta-analysis
We anticipate that a network meta-analysis will be per-
formed to allow estimation of the relative effects of every
duration of bed rest regardless of whether they have
been compared directly in head-to-head trials.General approach We will perform frequentist network
meta-analysis in R using the mvmeta package [27] for
most analyses. For analyses not yet feasible with the
above-mentioned package, we will use the mvmeta com-
mand [28] in STATA 13, including self-programmed
STATA routines available at http://www.mtm.uoi.gr.Assessment of statistical heterogeneity We will as-
sume a common estimate for the heterogeneity variance
across comparisons. The assessment of statistical hetero-
geneity in the entire network will be based on the mag-
nitude of the heterogeneity variance parameter (τ2)
estimated from the network meta-analysis models. We
will also estimate a total I-squared value for heterogen-
eity in the network [29].Transitivity To infer about the assumption of transitiv-
ity, we will assess whether the included bed rest dura-
tions are similar when they are evaluated in RCTs with
different designs, and we will compare the distribution
of the potential effect modifiers (for example, size of
catheter and presence of procedures to promote haemo-
stasis) across the different pairwise comparisons [30].Assessment of local statistical inconsistency We will
use a loop-specific approach to evaluate the consistency
assumption in each closed loop of the network. In our
study, a loop of evidence would be formed by at least
three categories of bed rest duration which have been
compared in studies. A loop-specific approach evaluates
the consistency assumption in each closed loop separately
as the difference between direct and indirect estimates for
a specific comparison in the loop (inconsistency factor).
We will look at the 95% confidence interval of the incon-
sistency factor to infer whether there is evidence of a dif-
ference between direct and indirect estimates. We will
assume a common heterogeneity estimate within each
loop [28,31]. We will interpret findings with caution due
the increased likelihood of type I error arising from mul-
tiple testing [32].
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the assumption of consistency in the entire network, we
will use a design-by-treatment model [33]. This method
accounts for different sources of inconsistency that can
occur when studies with different designs (for example,
two-arm trials vs. three-arm trials) give different results
as well as disagreement between direct and indirect evi-
dence. Using this approach, we will infer about the pres-
ence of inconsistency from any source in the entire
network based on a chi-square test. To distinguish be-
tween inconsistency and heterogeneity, we will employ
the I-squared for inconsistency that measures the percent-
age of variability that cannot be attributed to random
error or heterogeneity (within comparison variability).
Dealing with heterogeneity and inconsistency If we
find important heterogeneity or/and inconsistency, we
will explore the possible sources. If sufficient studies are
available, we will perform meta-regression by including
potential effect modifiers of the associations between
bed rest duration and outcome [30].
Sensitivity analysis
To incorporate the assessment of risk of bias in the re-
view process, we will plot intervention effects estimates
for different outcomes stratified for risk. If we find dif-
ferences in results by risk of bias and if the number of
included studies is sufficient, we will perform sensitivity
analysis excluding studies with high risk of bias from the
analysis.
Discussion
The aim of this systematic review is to assess the effects
of different lengths in bed rest after cardiac catheterisa-
tion on patient-level outcomes such as vascular compli-
cations, symptoms and satisfaction. Knowing to what
extent different lengths of bed rest can affect quality of
care and patient comfort may have considerable implica-
tions for practice, by grounding clinical decision in a
transparently selected pool of studies and by allowing
more efficient, evidence-based management of resources
for millions of patients worldwide [1].
We feel that publication of our review protocol prior to
conduction of our systematic review would encourage
transparency and would reduce risk of selection bias, as well
as reducing the possibility of methodological inaccuracies.
Our work would also have the advantage of consider-
ing for inclusion studies indexed in the EMBASE data-
set, a large biomedical database which was not searched
in a previous review [34,35]. Since we plan to consider
for inclusion also studies embed in previous reviews,
our review will be built on top of previous work, likely
expanding and updating their evidence base.Lastly, it seems reasonable to expect that some studies
might report the effects of different duration of bed rest,
with considerable heterogeneity for both the interven-
tion group and the comparison group. In such a case,
our review would summarise data by using a network
meta-analysis approach. This methodology would allow
obtaining effect estimates from both direct and indirect
comparisons, thus allowing more accurate predictions
which are likely to result in more reliable recommenda-
tions about the optimal length of bed rest after cardiac
catheterisation.
Endnote
aFor example, if a study compared 8 hvs. 10 h, both
arms would fall into the same category (‘8 to 11.9 h’) de-
fined according to a previous study [22]. We would thus
split that category into two new categories (for example, ‘8
to 9.9 h’ and ‘10 to 11.9 h’), to allow comparison of study
arms. If another study compared 8-h bed rest duration
with 9.5 h, then both study arms would fall into the ‘8 to
9.9 h’ category. We would therefore change the ‘8 to 9.9 h’
category into ‘8 to 9.4 h’ and the ‘10 to 11.9 h’ category
into ‘9.5 to 11.9 h’, in order to keep the number of categor-
ies of bed rest duration as small as possible while allowing
inclusion of as many studies possible.
Additional files
Additional file 1: Search strategies.
Additional file 2: EPOC criteria for quality assessment studies with
a separate control group (RCTs, CCTs, CBAs).
Abbreviations
CBAs: Controlled before and after studies; CCTs: Controlled clinical trials;
EPOC: Cochrane effective practice and organisation of care; NHS: National
health service; OR: Odds ratio; PICO: Population, intervention, comparison,
outcome; PRISMA: Preferred reporting items for systematic reviews and
meta-analyses; RCTs: Randomised control trials; SMD: Standardised mean
difference.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ADM, EA and FF conceived the design of the study and drafted the
manuscript. GB, FB and EB were involved in the design of the study and
drafting of the manuscript. SG and RC were involved in the design of the
study. ADM, EA and FF are guarantors of the review. All authors read and
approved the final manuscript.
Acknowledgements
We thank Dr. Fozia Hamid for her careful proofreading of the paper.
Funding
No specific founding was available for this review.
Author details
1School of Nursing, Biella Hospital, Corso Pella 10, 13900 Biella, Italy.
2Department of Translational Medicine, Università del Piemonte Orientale, Via
Salaroli 17, 28100 Novara, Italy. 3Internal Medicine, Ospedale degli Infermi, Via
Dei Ponderanesi 2, 13875 Ponderano - Biella, Italy. 4Nursing Home ‘Villa
Dal Molin et al. Systematic Reviews  (2015) 4:47 Page 6 of 6Poma’, Viale della Rimembranza 7, 13816 Miagliano, Biella, Italy. 5Inpatient
Neonatology/Neonatal Intensive Care Unit, Azienda Ospedaliero-Universitaria
Città della Salute e della Scienza di Torino, Ospedale Ostetrico Ginecologico
S.Anna, Corso Spezia 60, 10126 Torino, Italy. 6Semi Intensive Medicine and
Nephrology, Ospedale degli Infermi, Via Dei Ponderanesi 2, 13875 Ponderano -
Biella, Italy. 7Emergency Room, Ospedale degli Infermi, Via Dei Ponderanesi 2,
13875 Ponderano - Biella, Italy. 8School of Public Health, University of Torino, Via
Santena 5 bis, 10126 Torino, Italy.
Received: 11 October 2014 Accepted: 24 March 2015References
1. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary
intervention. N Engl J Med. 2011;364:453–64.
2. Chair SY, Thompson DR, Li SK. The effect of ambulation after cardiac
catheterization on patient outcomes. J Clin Nurs. 2007;16:212–4.
3. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence,
prognosis, and prevention. Circ Cardiovasc Interv. 2010;3:602–10.
4. Wood RA, Lewis BK, Harber DR, Kovack PJ, Bates ER, Stomel RJ. Early
ambulation following 6 French diagnostic left heart catheterization: a
prospective randomized trial. Cathet Cardiovasc Diagn. 1997;42:8–10.
5. Castillo-Sang M, Tsang AW, Almaroof B, Cireddu J, Sferra J, Zelenock GB,
et al. Femoral artery complications after cardiac catheterization: a study of
patient profile. Ann Vasc Surg. 2010;24:328–35.
6. Kern MJ, Cohen M, Talley JD, Litvack F, Serota H, Aguirre F, et al. Early
ambulation after 5 French diagnostic cardiac catheterization: results of a
multicenter trial. J Am Coll Cardiol. 1990;15:1475–83.
7. Roebucka A, Jessopb S, Turnerc R, Caplinb JL. The safety of two-hour versus
four-hour bed rest after elective 6-French femoral cardiac catheterization.
Coron Health Care. 2000;4:169–73.
8. Hamel WJ. Femoral artery closure after cardiac catheterization. Crit Care
Nurse. 2009;29:39–46. quiz 47.
9. Kussmaul WG, Buchbinder M, Whitlow PL, Aker UT, Heuser RR, King SB, et al.
Rapid arterial hemostasis and decreased access site complications after
cardiac catheterization and angioplasty: results of a randomized trial of a
novel hemostatic device. J Am Coll Cardiol. 1995;25:1685–92.
10. Chair SY, Fernandez R, Lui MH-L, Lopez V, Thompson DR. The clinical
effectiveness of length of bed rest for patients recovering from
trans-femoral diagnostic cardiac catheterisation. Int J Evid Based Healthc.
2008;6:352–90.
11. Benson G. Changing patients’ position in bed after non-emergency
coronary angiography reduced back pain. Evid Based Nurs. 2004;7:19.
12. Lim R, Anderson H, Walters MI, Kaye GC, Norell MS, Caplin JL. Femoral
complications and bed rest duration after coronary arteriography. Am J
Cardiol. 1997;80:222–3.
13. Chair SY, Li KM, Wong SW. Factors that affect back pain among Hong Kong
Chinese patients after cardiac catheterization. Eur J Cardiovasc Nurs.
2004;3:279–85.
14. Moeini M, Moradpour F, Babaei S, Rafieian M, Khosravi A. Four hour
ambulation after angioplasty is a safe practice method. Iran J Nurs
Midwifery Res. 2010;15:109–14.
15. Vlasic W. An evidence-based approach to reducing bed rest in the invasive
cardiology patient population. Evid Based Nurs. 2004;7:100–1.
16. Rezaei-Adaryani M, Ahmadi F, Mohamadi E, Asghari-Jafarabadi M. The effect
of three positioning methods on patient outcomes after cardiac
catheterization. J Adv Nurs. 2009;65:417–24.
17. Peterson JC, Allegrante JP, Pirraglia PA, Robbins L, Lane KP, Boschert KA,
et al. Living with heart disease after angioplasty: a qualitative study of
patients who have been successful or unsuccessful in multiple behavior
change. Heart Lung. 2010;39:105–15.
18. Keeling AW, Fisher CA, Haugh KH, Powers ER, Turner MS. Reducing time in
bed after percutaneous transluminal coronary angioplasty (TIBS III). Am J
Crit Care. 2000;9:185–7.
19. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al.
Preferred Reporting Items for Systematic Review and Meta-Analysis
Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
20. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. BMJ.
2009;339:b2535.21. Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical
question: a key to evidence-based decisions. ACP J Club. 1995;123:A12–3.
22. Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment
needing more careful evaluation. Lancet. 1999;354:1229–33.
23. Saldanha IJ, Dickersin K, Wang X, Li T. Outcomes in Cochrane systematic
reviews addressing four common eye conditions: an evaluation of
completeness and comparability. PLoS One. 2014;9, e109400.
24. Altman DG. Practical statistics for medical research. London: Chapman &
Hall; 1992.
25. Cochrane Handbook for systematic reviews of interventions. [http://
handbook.cochrane.org/].
26. Viechtbauer W. Conducting meta-analyses in R with the metafor package.
J Stat Softw. 2010;36:1–48.
27. Gasparrini A, Armstrong B, Kenward MG. Multivariate meta-analysis for
non-linear and other multi-parameter associations. Stat Med.
2012;31:3821–39.
28. White IR, Barrett JK, Jackson D, Higgins JPT. Consistency and
inconsistency in network meta-analysis: model estimation using
multivariate meta-regression. Res Synth Methods. 2012;3:111–25.
29. Jackson D, White IR, Riley RD. Quantifying the impact of between-study
heterogeneity in multivariate meta-analyses. Stat Med. 2012;31:3805–20.
30. Jansen JP, Naci H. Is network meta-analysis as valid as standard pairwise
meta-analysis? It all depends on the distribution of effect modifiers. BMC
Med. 2013;11:159.
31. Lu G, Ades AE. Assessing evidence inconsistency in mixed treatment
comparisons. J Am Stat Assoc. 2006;101(474):447–59.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J R Stat Soc Ser B.
1995;57:289–300.
33. Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and
inconsistency in network meta-analysis: concepts and models for multi-arm
studies. Res Synth Methods. 2012;3:98–110.
34. Mohammady M, Heidari K, Akbari Sari A, Zolfaghari M, Janani L. Early
ambulation after diagnostic transfemoral catheterisation: a systematic
review and meta-analysis. Int J Nurs Stud. 2014;51:39–50.
35. Mohammady M, Atoof F, Sari AA, Zolfaghari M. Bed rest duration after
sheath removal following percutaneous coronary interventions: a systematic
review and meta-analysis. J Clin Nurs. 2014;23:1476–85.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
